CARL ZEISS MEDITEC’S NEAR-TERM OUTLOOK DIMS (SELL; 11% DOWNSIDE)
16/11/20 -"At the start of 2020, Carl Zeiss Meditec/CZM (Sell, Germany) was trading at its life-time high levels as the FY 18/19 (ending September 2019) sales growth and operating margin hit record highs – ..."
Pages
60
Language
English
Published on
16/11/20
You may also be interested by these reports :
22/01/26
CZM’s Q1 FY 2025-26 preliminary release fell short of market expectations. Sales and profitability were adversely affected by both external and ...
19/01/26
Drägerwerk has delivered solid FY25 preliminary numbers. The key surprise was EBIT, which beat consensus by c.18%, reflecting better gross margins ...
15/01/26
In late-2024, when we last teased the story of DiaSorin (BUY; Italy), a family-owned in-vitro diagnostic company specialising in immunodiagnostics ...
07/01/26
Yesterday, Meta announced a delay in the international rollout of the Ray-Ban display smart glasses. The market reacted positively to this news, on ...